Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Equity Average (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Equity Average for 6 consecutive years, with $137.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average rose 6.57% year-over-year to $137.6 million, compared with a TTM value of $137.6 million through Dec 2025, up 6.57%, and an annual FY2025 reading of $136.5 million, up 11.27% over the prior year.
  • Equity Average was $137.6 million for Q4 2025 at Viemed Healthcare, roughly flat from $137.6 million in the prior quarter.
  • Across five years, Equity Average topped out at $139.2 million in Q2 2025 and bottomed at $82.6 million in Q1 2021.
  • Average Equity Average over 5 years is $109.0 million, with a median of $104.5 million recorded in 2023.
  • The sharpest move saw Equity Average soared 41.49% in 2021, then rose 3.29% in 2023.
  • Year by year, Equity Average stood at $92.1 million in 2021, then grew by 3.7% to $95.5 million in 2022, then grew by 16.6% to $111.4 million in 2023, then grew by 15.93% to $129.1 million in 2024, then rose by 6.57% to $137.6 million in 2025.
  • Business Quant data shows Equity Average for VMD at $137.6 million in Q4 2025, $137.6 million in Q3 2025, and $139.2 million in Q2 2025.